Boobalan Pachaiyappan's Stock Ratings

Roth Capital Analyst

Boobalan Pachaiyappan is an analyst at Roth Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/19/2025

Overall Average Return

9.83%

Smart Score

54.4%

Overall Average Return Percentile

60th

Number of Ratings

15
Buy NowGet Alert
06/18/2025VRNABuy Now
Verona Pharma
$91.8926.24%
Boobalan Pachaiyappan54%
$92 → $116ReiteratesBuy → BuyGet Alert
06/18/2025PYPDBuy Now
PolyPid
$3.28174.39%
Boobalan Pachaiyappan54%
$12 → $9MaintainsBuyGet Alert
06/17/2025CAPRBuy Now
Capricor Therapeutics
$10.95183.11%
Boobalan Pachaiyappan54%
$31 → $31ReiteratesBuy → BuyGet Alert
06/05/2025PYPDBuy Now
PolyPid
$3.28174.39%
Boobalan Pachaiyappan54%
→ $9Initiates → BuyGet Alert
05/19/2025CINGBuy Now
Cingulate
$4.58140.17%
Boobalan Pachaiyappan54%
$12 → $11MaintainsBuyGet Alert
03/18/2025CRVOBuy Now
CervoMed
$6.90189.86%
Boobalan Pachaiyappan54%
$15 → $20MaintainsBuyGet Alert
03/11/2025CRVOBuy Now
CervoMed
$6.90117.39%
Boobalan Pachaiyappan54%
$7 → $15MaintainsBuyGet Alert
01/10/2025VRNABuy Now
Verona Pharma
$91.89-26%
Boobalan Pachaiyappan54%
→ $68Initiates → BuyGet Alert
01/10/2025RVPHBuy Now
Reviva Pharmaceuticals
$0.69915.52%
Boobalan Pachaiyappan54%
→ $7Initiates → BuyGet Alert
01/10/2025CINGBuy Now
Cingulate
$4.58162.01%
Boobalan Pachaiyappan54%
→ $12Initiates → BuyGet Alert
12/24/2024GANXBuy Now
Gain Therapeutics
$1.76297.73%
Boobalan Pachaiyappan54%
$7 → $7MaintainsBuyGet Alert
12/05/2024CRVOBuy Now
CervoMed
$6.90552.17%
Boobalan Pachaiyappan54%
→ $45Initiates → BuyGet Alert
12/05/2024TRDABuy Now
Entrada Therapeutics
$7.03312.52%
Boobalan Pachaiyappan54%
→ $29Initiates → BuyGet Alert
12/05/2024GANXBuy Now
Gain Therapeutics
$1.76297.73%
Boobalan Pachaiyappan54%
→ $7Initiates → BuyGet Alert
12/05/2024LGVNBuy Now
Longeveron
$1.26693.65%
Boobalan Pachaiyappan54%
→ $10Initiates → BuyGet Alert